How Phamax added compliant content editing without sacrificing its AI roadmap
Phamax uses Polotno SDK inside Ariya, its pharma-trained AI platform, to let brand teams refine compliant emails, banners, and promotional materials. They shipped an editing experience in weeks instead of months and kept engineering focused on their real differentiator: domain-specific AI for the healthcare industry.
Avoiding a year-long infrastructure detour
Ariya generates pharma-safe, brand-aligned content using domain-trained AI. But generation alone does not complete the workflow. Brand managers and omnichannel teams must refine layouts, adjust messaging, and finalize assets before distribution — all within a highly regulated environment.
Phamax faced a structural decision. Building even a stripped-down editor would require an estimated 2–3 months of engineering. Achieving production-grade reliability and long-term maintainability could extend toward a year of development. That effort would not strengthen Ariya’s core differentiator — its pharma-trained AI engine — and would introduce a second product to build, maintain, and secure in a compliance-sensitive market.
They needed an editing layer that could live inside Ariya, preserve regulatory control, and avoid pulling engineering focus away from AI innovation.
Integrating Polotno as Ariya's editing layer in ~2 weeks
Phamax embedded Polotno SDK directly into Ariya’s creation flow as its content-editing layer. The integration was completed in approximately two weeks.
AI generates compliant drafts. Users refine those drafts visually inside a controlled canvas environment. Editing happens natively within Ariya — no exports, no external tools, and no compliance gaps.
Polotno absorbed the complexity of layout management, rendering logic, and browser-based canvas behavior. Phamax avoided 3+ months of stripped-down editor development and up to a year of production-grade buildout, preserving engineering capacity for advancing their domain-specific AI. The editor became infrastructure, not a side project.
Compliant content, end to end
Polotno now sits at the critical transition point between AI generation and final asset delivery. Pharma teams refine materials daily within a stable, browser-based environment embedded directly into Ariya.
Phamax maintained full momentum on its AI roadmap while delivering an end-to-end compliant workflow. There is no second system to maintain, no parallel product track to manage, and no vendor-driven disruption risk in the editing layer.
The result is a unified platform where AI intelligence and controlled editing coexist — allowing Phamax to scale innovation without taking on the burden of building and maintaining editor infrastructure.